Karman Holdings 株価情報 (NYSE: KRMN)

最新ニュース Karman Holdings (NYSE:KRMN) 株価情報

Karman Holdings Inc specializes in the upfront design, testing, manufacturing, and sale of mission-critical systems for existing and emerging missile and defense, and space programs. Its integrated payload protection, propulsion, and interstage system solutions are deployed across a wide variety of existing and emerging programs supporting important Department of Defense (DoD) and space sector initiatives. Its engineered solutions are organized into three key families: Payload Protection and Deployment Systems, Aerodynamic Interstage Systems, and Propulsion Systems. The company's solutions are deployed across three growing, core end markets: Hypersonics & Strategic Missile Defense, Missile & Integrated Defense Systems, and Space & Launch.

Karman Holdings Inc

Truist Securities analyst Neal Dingmann maintains Kodiak Gas Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGS#NYSE">KGS</a>) with a Buy and raises the price target from $45 to $47.

News

Price Target

Analyst Ratings

Truist Securities Maintains Buy on Kodiak Gas Services, Raises Price Target to $47

Macro Economic Events

Econ #s

Economics

EIA Sees 2025 U.S. Oil Output Of 13.61M Barrel/Day, Vs Prior Forecast 13.59M Barrel/Day; Sees 2026 Output Of 13.76M Barrel/Day; Sees 2025 U.S. NatGas Output Of 105.2 BCF/Day, Vs Prior Forecast 104.6 BCF/Day; Sees 2026 Demand Of 107.5 BCF/Day; Sees 2025 U.S. Oil Demand Of 20.5M Barrel/Day, Vs Prior Forecast 20.5M Barrel/Day; Sees 2026 Demand Of 20.6M Barrel/Day; Sees 2025 U.S. NatGas Demand Of 92 BCF/Day, Vs Prior Forecast 90.7 BCF/Day; Sees 2026 Demand Of 91.1 BCF/Day

Truist Securities analyst Asthika Goonewardene maintains Genmab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMAB#NASDAQ">GMAB</a>) with a Buy and lowers the price target from $50 to $45.

GMAB

Truist Securities Maintains Buy on Genmab, Lowers Price Target to $45

WIIM

FRSX

Foresight Autonomous Holdings shares are trading higher after the company announced it secured a $2.75 million investment.

Guess? shares are trading lower after UBS cut its price target on the stock from $15 to $12.

Trading Ideas

Live On CNBC, Bryn Talkington Announces Bought Apollo Global Management And KKR & Co.

JP Morgan analyst Matthew Boss maintains Kohl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) with a Underweight and lowers the price target from $11 to $9.

JP Morgan Maintains Underweight on Kohl's, Lowers Price Target to $9

Mizuho analyst Gregg Moskowitz maintains ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Outperform and lowers the price target from $1210 to $1100.

Mizuho Maintains Outperform on ServiceNow, Lowers Price Target to $1100

Arvinas, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) and Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) released topline results from the Phase 3 VERITAC-2 trial evaluating vepdegestrant monotherapy versus fulvestrant in adult patients with advanced or <a href="https://www.benzinga.com/general/biotech" target="_blank" rel="noreferrer noopener">metastatic breast cancer</a>.
The results of the trial, released Monday, included estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer patients whose disease progressed following prior treatment with cyclin-dependent kinase (CDK) 4/6 inhibitors and endocrine therapy.
These are the first pivotal<a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44242539/arvinas-and-pfizer-announce-positive-topline-results-from-phase-3-veritac-2-clinical-trial" rel="noreferrer noopener"> data for vepdegestrant</a>.
The trial met its primary endpoint in the estrogen receptor 1-mutant (ESR1m) population, demonstrating a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to fulvestrant.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42421011/arvinas-pfizer-partner-cancer-cancer-drug-shows-63-clinical-benefit-rate-in-combo-therapy-trial-in-breast-cancer-patients" rel="noreferrer noopener">Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Clinical Benefit In Breast Cancer Patients</a>
The results exceeded the pre-specified target hazard ratio of 0.60 in the ESR1m population.
The trial did not reach statistical significance in improvement in PFS in the intent-to-treat (ITT) population.
Overall survival was not mature at the time of the analysis, with less than a quarter of the required number of events having occurred.
The trial will continue to assess overall survival as a key secondary endpoint.
In the trial, vepdegestrant was generally well tolerated.
Detailed results from VERITAC-2 will be submitted for presentation at a medical meeting later this year.
In February 2024, the U.S. Food and Drug Administration (FDA) granted Fast Track designation for vepdegestrant for monotherapy for adults with ER+/HER2- advanced or metastatic breast cancer previously treated with endocrine-based therapy.
Price Action: ARVN stock is down 52.4% at $8.35 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/03/44249407/bristol-myers-squibb-scoops-up-its-blood-cancer-drug-partner-2seventy-bio-in-286-million-deal" target="_blank" rel="noreferrer noopener">Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal</a></li>
</ul>
Image: Shutterstock

Biotech

Large Cap

Health Care

Movers

General

ARVN

Arvinas, Pfizer Breast Cancer Drug Fails To Show Progression-Free Survival Benefit In Trial

Ford Motor's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) short percent of float has risen 37.61% since its last report. The company recently reported that it has 161.21 million shares sold short, which is 4.5% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.6 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Ford Motor Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741710628_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ford Motor has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Ford Motor's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Ford Motor's peer group average for short interest as a percentage of float is 8.20%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Peering Into Ford Motor's Recent Short Interest

Adobe's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NYSE">ADBE</a>) short percent of float has fallen 3.95% since its last report. The company recently reported that it has 7.37 million shares sold short, which is 1.7% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.47 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Adobe Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741710623_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Adobe has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Adobe's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Adobe's peer group average for short interest as a percentage of float is 3.04%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

ADBE

Is Adobe Gaining or Losing Market Support?

Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) has outperformed the market over the past 10 years by 11.28% on an annualized basis producing an average annual return of 21.6%. Currently, Stride has a market capitalization of $5.19 billion. 
Buying $1000 In LRN: If an investor had bought $1000 of LRN stock 10 years ago, it would be worth $7,079.03 today based on a price of $119.21 for LRN at the time of writing.
<h3>Stride's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741710617_0_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Stride 10 Years Ago Would Be Worth This Much Today

Westinghouse Air Brake's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAB#NYSE">WAB</a>) short percent of float has risen 10.74% since its last report. The company recently reported that it has 2.45 million shares sold short, which is 1.65% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.7 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Westinghouse Air Brake Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741710617_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Westinghouse Air Brake has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Westinghouse Air Brake's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Westinghouse Air Brake's peer group average for short interest as a percentage of float is 5.60%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into Westinghouse Air Brake's Recent Short Interest

DA Davidson analyst Michael Shlisky maintains Toro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTC#NYSE">TTC</a>) with a Neutral and lowers the price target from $86 to $80.

DA Davidson Maintains Neutral on Toro, Lowers Price Target to $80

DA Davidson analyst Brian Holland maintains The Campbell's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NASDAQ">CPB</a>) with a Neutral and lowers the price target from $46 to $39.

DA Davidson Maintains Neutral on The Campbell's, Lowers Price Target to $39

Meta&nbsp;Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)&nbsp;is testing its first <a target="_blank" href="https://www.benzinga.com/topic/chip-stocks" rel="noreferrer noopener">in-house chip</a> for training artificial intelligence systems. This marks its efforts to reduce reliance on suppliers like Nvidia&nbsp;Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and bring down its infrastructure costs to offset the impact of its bets on AI tools to drive growth.
Meta tapped Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) to produce the chip, Reuters reported, citing unnamed sources familiar with the matter.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44245409/microchip-launches-new-pic32a-chips-for-ai-auto-medical-and-industrial-applications" rel="noreferrer noopener">Microchip Launches New PIC32A Chips For AI, Auto, Medical, and Industrial Applications</a>
Meta told Reuters they want to use their chips by 2026 for training.
In 2024, Meta started using a Meta Training and Inference Accelerator (MTIA) chip to perform inference.
As with the inference chip, the training chip aims to start with recommendation systems and later use them for generative AI products like chatbot Meta AI.
The Facebook and Instagram parent company has begun deploying a small chip and plans to ramp up production for wide-scale use if the test goes well.
Meta expects total 2025 expenses&nbsp;of $114 billion—$119 billion, including up to $65 billion in capital expenditures driven by AI infrastructure spending.
Meta previously&nbsp;scrapped an in-house custom inference chip.
Since then, Meta has remained one of Nvidia&#8217;s leading customers.
The&nbsp;AI chip market was worth $61.45 billion in 2023 and is expected to reach $621.15 billion by 2032, growing at a CAGR of 29.4% over the forecast period <a target="_blank" href="https://www.globenewswire.com/news-release/2024/10/28/2970177/0/en/AI-Chip-Market-Expected-to-Reach-USD-621-15-Billion-by-2032-at-Rising-CAGR-of-29-4-Exclusive-Report-by-S-S-Insider.html" rel="noreferrer noopener">2024-2032</a>.
Big Tech giants remain engaged in their endeavors to develop in-house chips to reduce dependence on suppliers.
Reportedly, OpenAI&nbsp;is <a target="_blank" href="https://www.benzinga.com/markets/equities/25/02/43591228/sam-altmans-openai-set-to-finalize-in-house-ai-chip-reducing-dependence-on-nvidia-report" rel="noreferrer noopener">nearly ready to</a> finalize the design for its&nbsp;first proprietary AI chip, which could reduce the company&#8217;s reliance on&nbsp;Nvidia.
OpenAI is on track to achieve its goal of commercializing at Taiwan Semiconductor by 2026.&nbsp;
Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) reportedly collaborated with Taiwan Semiconductor <a target="_blank" href="https://www.benzinga.com/24/12/42487128/apples-2025-chip-transition-targets-new-wireless-edge-broadcom-to-retain-key-role" rel="noreferrer noopener">to launch in-house</a> Wi-Fi and Bluetooth chips by 2025.
Price Action: META stock is up 1% at $604.00 at last check Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44245291/ciena-q1-earnings-revenue-and-eps-beat-estimates-ceo-eyes-ai-cloud-network-tailwinds" target="_blank" rel="noreferrer noopener">Ciena Q1 Earnings: Revenue and EPS Beat Estimates, CEO Eyes AI, Cloud Network Tailwinds</a></li>
</ul>
Photo: Shutterstock

Tech

Media

AAPL

NVDA

Meta Taps Taiwan Semiconductor To Build AI Chip, Aims To Cut Nvidia Dependence By 2026

TSLA

Live On CNBC, Bryn Talkington Announces Bought More Tesla

Another member of Congress has disclosed buying shares of a Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) ETF ahead of President Donald Trump's announcement for a planned <a href="https://www.benzinga.com/25/03/44183572/trump-establishes-strategic-bitcoin-reserve-funded-by-forfeited-assets-i-made-the-promise">Strategic Bitcoin Reserve.</a>
What Happened: Trump ally Marjorie Taylor Greene (R-Ga.) recently disclosed buying shares of a Bitcoin ETF, according to the<a href="https://www.benzinga.com/gov-trades/members/marjorie-taylor-greene"> Benzinga Government Trades page.</a>
Greene follows Senator David McCormick (R-Pa.) who also <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44194484/congressman-on-digital-assets-subcommittee-buys-bitcoin-etf-before-trumps-strategic-reserve-announcement">recently disclosed buying</a> shares of a Bitcoin ETF before a social media post from Trump announcing plans for a Strategic Bitcoin Reserve.
Greene's purchase of shares of iShares Bitcoin Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) happened on March 3 — after Trump&#8217;s social media post, but before he signed an executive order for Bitcoin Strategic Reserve. The purchase price was $15,000 to $50,000.
In the latest disclosure, Greene also announced buying $1,000 to $15,000 worth of the following stocks:
<ul>
<li>CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>)</li>
<li>Dollar General (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) &#8211; $2,000 to $30,000 total from two purchases</li>
<li>Goldman Sachs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>)</li>
<li>Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)</li>
<li>Impinj Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>)</li>
</ul>
The latest disclosure from Greene continues a series of heavy trading activity in 2024 and 2025 after limited buying and selling of stocks in 2022 and 2023 while in Congress.
Read Also: <a href="https://www.benzinga.com/25/01/42860759/10-best-stock-traders-in-congress-in-2024-where-do-nancy-pelosi-pete-sessions-susan-collins-marjorie-taylor-greene-rank">Top 10 Stock Traders In Congress For 2024: How Nancy Pelosi, Pete Sessions, Susan Collins, Marjorie Taylor Greene Rank</a>
Why It's Important: Unlike Greene&#8217;s <a href="https://www.benzinga.com/25/02/43796040/marjorie-taylor-greene-discloses-new-stock-trades-palantir-purchase">recent purchase </a>of Palantir Technologies, the latest purchases don't have immediate red flags related to her congressional committee assignments.
Instead, the purchases of a Bitcoin ETF and Tesla stock could draw scrutiny due to her close relationship with President Trump and billionaire and Tesla CEO Elon Musk.
Greene has a role within the Department of Government Efficiency, which could give her increased access to Musk.
Trump ran on a platform of being pro-crypto during the 2024 election and his announced plans for a Bitcoin Strategic Reserve don't come as a surprise. Greene's timing of the Bitcoin ETF shares still draws red flags as it was after his social media post and could have been done with knowledge of when an executive order would be signed.
For the record, Greene also bought $1,000 to $15,000 shares of IBIT back in January.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="http://Did You Know? •	Congress Is Making Huge Investments. Get Tips On What They Bought And Sold With Our Easy-to-Use Tool">Get Tips On What They Bought And Sold With Our Easy-to-Use Tool</a></li>
</ul>
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent031125"><img loading="lazy" decoding="async" width="1024" height="330" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/11120059/Picture1-4-1024x330.png" alt="" class="wp-image-819128" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/11120059/Picture1-4-1024x330.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/11120059/Picture1-4-300x97.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/11120059/Picture1-4-768x248.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/11120059/Picture1-4.png 1430w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Politics

$BTC

CRWD

IBIT

Marjorie Taylor Greene Buys More Bitcoin ETF Shares Ahead Of Trump's Strategic Reserve Executive Order

BMO Capital analyst Keith Bachman maintains Telos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLS#NASDAQ">TLS</a>) with a Market Perform and lowers the price target from $4.5 to $3.

Comments

Karman Holdings

ニュース

最新ニュース Karman Holdings (NYSE:KRMN) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル